Key Takeaway
After scoring 105 telehealth providers on purity testing, BBB rating, pharmacy credentials, and true monthly cost, FormBlends scored highest (78/100) followed by Eden (70) and ShedRx (68). Mochi, MEDVi, Lemonaid, and Henry Meds round out the top seven, though Henry Meds carries an F BBB rating and is listed for transparency only.
Picking a compounded GLP-1 provider in 2026 is harder than it was a year ago. The FDA resolution of the semaglutide and tirzepatide shortages closed the official 503A compounding lane for mass-market prescribing, then reopened it for personalized formulations. Some providers adapted cleanly. Others kept selling identical-to-brand copies and started collecting FDA warning letters and Eli Lilly lawsuits.
We pulled BBB files, FDA enforcement records, Certificates of Analysis (COAs), pharmacy accreditations, and pricing pages for 105 providers. Seven passed the basic safety floor. Here's how they stack up.
How we scored 105 GLP-1 providers
Each provider earned up to 100 points across four weighted categories: purity and testing (30 points), regulatory record (25 points), pharmacy credentials (25 points), and true cost transparency (20 points). A provider had to score 50 or higher and have no active FDA warning letter in good standing to make the top seven.
Purity testing is scored by whether the provider publishes third-party Certificates of Analysis for every batch, tests both active ingredient concentration and endotoxin levels, and makes COAs available to patients on request. The regulatory score pulls from FDA 483 observations, warning letters, and BBB complaint history. Pharmacy credentials cover NABP, PCAB, and ACHC accreditation. Cost transparency checks whether the advertised price includes consultation, shipping, and all doses, or whether hidden escalators kick in at higher titration.
You can see every data point behind each score in the 2026 State of GLP-1 Telehealth report, which also lists the 98 providers that didn't make the cut.
The top 7 compounded GLP-1 providers ranked
Here's the full ranking with scores, price, BBB, and the single strength that pushed each provider above the 50-point floor. Scores are out of 100. Prices are starting monthly cost, not the cost at full titration.
| Rank | Provider | Score | Monthly cost | BBB | Key strength |
|---|---|---|---|---|---|
| 1 | FormBlends | 78 | $199 | A | Third-party COAs every batch |
| 2 | Eden | 70 | $249 | A | Flat rate at any dose |
| 3 | ShedRx | 68 | $129 | A | 4 formats, 10% loss guarantee |
| 4 | Mochi Health | 60 | $99 + $79 mem. | B | LegitScript certified |
| 5 | MEDVi | 58 | $179 | F | No contract lock-in |
| 6 | Lemonaid / 23andMe | 55 | $299 + $49 mem. | B | Genomic data option |
| 7 | Henry Meds* | 35 | $119-149 | F | Low entry price (transparency only) |
*Henry Meds is included for transparency because of its search visibility, but its F BBB rating and active Eli Lilly lawsuit put it below our safety floor. We do not recommend it.
1. FormBlends (78/100)
FormBlends scored highest because of third-party COAs on every batch, no FDA warning letters, and a published 7,282-provider directory that lets you verify any prescriber's state license and DEA number. The flat $199 monthly price includes consultation, shipping, and all doses. The main weakness is the lack of a native mobile app. Everything runs through a mobile-responsive web dashboard. See FormBlends products or start a consultation.
2. Eden (70/100)
Eden charges $249 flat across every dose, which matters because other providers often start cheap and double the price at the 2.4mg semaglutide or 15mg tirzepatide tier. Eden routes prescriptions through NABP, PCAB, and ACHC-accredited pharmacies, publishes third-party testing, and holds a 4.5-star average. Brand recognition is limited compared to larger players, so patient protection depends on the accreditation stack rather than a household name.
3. ShedRx (68/100)
ShedRx sells semaglutide and tirzepatide in four formats: subcutaneous injection, sublingual drops, lozenges, and tablets. It offers a 10% weight-loss guarantee over 9 months, which is unusual in this market. BBB rating sits at A after a corrective plan, though one of its pharmacy partners was disciplined by a state board in 2025. Entry pricing is $129 monthly, which is the lowest flat rate in the top five.
4. Mochi Health (60/100)
Mochi Health runs $99 monthly for compounded semaglutide plus a $79 membership, so true monthly cost is $178. Its LegitScript certification is real and currently in good standing. The deductions on Mochi's score come from an active Eli Lilly lawsuit filed in late 2025 and documented cold-chain shipping failures where product arrived warm in summer shipments. If you order from Mochi, request expedited shipping and check the cold pack on arrival.
5. MEDVi (58/100)
MEDVi charges $179 monthly with no contract and reported $401 million in revenue for 2025 with only two listed employees, which tells you most of the operation is outsourced. The F BBB rating and a February 2026 FDA warning letter dropped its score below the top three. If price and no-contract flexibility are your top priorities and you've read the warning letter, MEDVi is still above the 50-point safety floor, but you're accepting higher risk.
6. Lemonaid / 23andMe (55/100)
Lemonaid is now owned by 23andMe, which means your GLP-1 prescription data can be optionally linked to your genomic profile. That's either a feature or a privacy concern depending on your view. Pricing is $299 for semaglutide plus $49 membership, making it the most expensive in the top seven. The B BBB rating is solid but the cost-to-value ratio is weaker than Eden or FormBlends.
7. Henry Meds (35/100)
Henry Meds is the most-searched compounded GLP-1 brand in 2026, but its score is below our recommendation floor. The F BBB rating shows zero responses to customer complaints over a 12-month period. Reviews have been flagged for authenticity issues. There's an active Eli Lilly lawsuit tied to tirzepatide compounding. We list Henry Meds only because readers search for it, not because we'd point anyone to it. Read the red flag guide before signing up anywhere with an F BBB.
Why purity testing (COAs) matters most
A Certificate of Analysis is a lab report from a third-party (not the pharmacy) showing what's actually in the vial. For compounded semaglutide or tirzepatide, you want to see two numbers: active ingredient concentration within plus or minus 5% of label, and endotoxin levels below 0.5 EU/mg. Without both, you don't know what you're injecting.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →The 2024 JAMA Network Open analysis of compounded semaglutide vials found potency variation ranging from 74% to 142% of labeled dose across samples from providers that did not publish COAs. Providers that did publish batch-level COAs showed potency within 3% of label. That's the single biggest safety delta in this market. This guide shows you how to read a COA in about three minutes.
If a provider won't send you a COA for your specific batch on request, treat that as disqualifying. Every top-three provider above will email you the COA within 48 hours. You can cross-reference batch numbers against the provider directory to confirm the pharmacy is real.
The providers we DO NOT recommend
Out of 105 providers scored, 98 fell below our 50-point floor. The most common failure modes were no third-party testing (41 providers), active FDA warning letters (12 providers), F BBB ratings with zero complaint responses (23 providers), and pricing that tripled between entry dose and full titration without disclosure (31 providers, some overlap).
Three brand categories to avoid entirely in 2026: providers that ship from overseas pharmacies without a US-licensed prescriber on file, providers that sell "research-only" or "not for human use" peptides while implying medical guidance, and any operation that requires a deposit before a medical consultation. None of these patterns appear in the top seven above.
We also exclude any provider currently under FDA 483 observation where corrective action hasn't been verified. That list changes monthly, so check the main report for the current version.
Compounded vs brand-name: when each makes sense
Compounded GLP-1s make sense when you need a personalized dose or combination (like semaglutide with B12), when brand-name Wegovy or Zepbound is out of stock in your zip code, or when insurance refuses to cover the brand and the $1,000+ monthly cash price is out of reach. Compounded cash prices run $119 to $299 monthly depending on provider.
Brand-name Wegovy and Zepbound are worth the extra cost when you have insurance coverage that caps out-of-pocket at under $100 monthly, when you have a complex medical history that needs the exact dosing profile from the STEP 1 (Wilding et al., NEJM 2021) and SURMOUNT-1 (Jastreboff et al., NEJM 2022) trials, or when you're eligible for the Eli Lilly Direct or Novo Nordisk savings programs.
A practical middle path: start on compounded to see if GLP-1 therapy works for your body, then switch to brand-name if your insurance kicks in or the savings program qualifies you. Many FormBlends patients do exactly this.
Questions to ask any provider before signing up
Before you enter a credit card, email or call the provider and ask these five questions. If you can't get clear answers within one business day, that's your answer.
- Can you send me a third-party Certificate of Analysis for my batch before I inject?
- What is the total monthly cost at the 2.4mg semaglutide or 15mg tirzepatide dose, including consultation and shipping?
- Which pharmacy will fulfill my prescription, and is it NABP, PCAB, or ACHC accredited?
- Is there an active FDA warning letter or state pharmacy board action against your pharmacy partner?
- If I want to cancel, what's the process and are there any unused-dose fees?
Every top-seven provider should be able to answer all five in writing. If the answer to question one is "we don't provide COAs to patients," stop there. This red flag guide covers 12 more warning signs.
Frequently asked questions
What is the safest compounded GLP-1 provider in 2026?
By our scoring, FormBlends ranked highest at 78/100 because of third-party COAs on every batch, no FDA warnings, and transparent pricing. Eden (70) and ShedRx (68) are the next-safest options. Disclosure: this article is on FormBlends own site, but we applied the same methodology to every provider and the scoring is public.
Is compounded semaglutide still legal in 2026?
Yes, under the 503A personalized compounding pathway. What changed is that mass-market identical-to-brand compounding is no longer protected by an official shortage. Legitimate providers now compound with meaningful personalization, like added B12 or custom dosing. Providers still selling generic copies at scale are the ones getting FDA warning letters and Lilly lawsuits.
How much does compounded semaglutide cost per month?
Between $99 and $299 monthly in the top seven, with most landing in the $179 to $249 range once you add mandatory memberships and shipping. FormBlends is $199 flat, Eden is $249 flat, and Mochi is $178 all-in. Watch for providers that advertise low entry prices but escalate at full titration.
Do I need a prescription for compounded GLP-1s?
Yes. Every legitimate provider requires an online medical consultation with a licensed prescriber before dispensing. Any site that ships compounded semaglutide or tirzepatide without a prescription is operating illegally. You can verify a prescriber's license through the FormBlends directory of 7,282 vetted providers.
What BBB rating should I look for in a GLP-1 provider?
A or better with responsive complaint history. Providers holding A ratings (FormBlends, Eden, ShedRx) typically respond to complaints within 14 days. F-rated providers (Henry Meds, MEDVi) often show zero responses, which means if something goes wrong with your shipment or side effects, you're on your own.
Why is Henry Meds ranked if you don't recommend it?
Because readers search for Henry Meds specifically, and we'd rather show you the real data than pretend the brand doesn't exist. A 35/100 score with an F BBB, flagged reviews, and an active Eli Lilly lawsuit should be enough information to steer you elsewhere. If you've already signed up, at minimum request a COA for your current batch before your next injection.
Can I switch providers mid-treatment?
Yes, and many patients do. Your new provider will typically honor your current dose level rather than restarting titration, as long as you provide your prescription history. FormBlends and Eden both accept mid-treatment transfers with a records review. Factor in a two-week gap for the transfer to avoid running out of medication.
Last reviewed: April 16, 2026. Scores and BBB ratings are accurate as of this date and can change. Check the main 2026 report for current data.
Medical disclaimer: This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before starting any medication. Individual results vary. FormBlends is a licensed telehealth platform; nothing here replaces a personal clinical evaluation.